lontrap is a research stage company that holds several granted patents for the rapid detection and identification of virus particles (virions) in breath. The detection method relies on the rapid catalytic breakdown of viral proteins into fragments of the constituent amino acids. Some of the fragments are electro positive and some electro negative and some have both electro positive and electro negative properties. This allows for extremely sensitive and selective detection in an ion drift detector operated in the dual mode for the detection of positive and negative ions.

We are working to produce a model to demonstrate detection capability, employing artificial intelligence to help identify the spectral response of virions in the spectral clutter from fragments of harmless mucal proteins. The detection process needs no sample preparation or clinical staff operator. Target response time will allow five hundred subjects to be tested per hour. The system is expected to find use in prevention of the spread of disease in high density applications such as cruise lines, airports, stadia, and industrial situations where thousands of people need to be rapidly screened.